Merck & Company Inc (MRK)vsTactile Systems Technology Inc (TCMD)
MRK
Merck & Company Inc
$120.79
-2.77%
HEALTHCARE · Cap: $285.64B
TCMD
Tactile Systems Technology Inc
$25.40
+0.91%
HEALTHCARE · Cap: $592.67M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 19045% more annual revenue ($65.77B vs $343.52M). MRK leads profitability with a 13.6% profit margin vs 5.9%. MRK appears more attractively valued with a PEG of 5.36. TCMD earns a higher WallStSmart Score of 52/100 (C-).
MRK
Hold50
out of 100
Grade: D+
TCMD
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-49.3%
Fair Value
$80.88
Current Price
$120.79
$39.91 premium
Intrinsic value data unavailable for TCMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Revenue surging 22.8% year-over-year
Areas to Watch
Premium valuation, high expectations priced in
4.9% revenue growth
Elevated debt levels
Weak financial health signals
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
5.9% margin — thin
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : TCMD
The strongest argument for TCMD centers on Debt/Equity, Altman Z-Score, Price/Book. Revenue growth of 22.8% demonstrates continued momentum.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.
Bear Case : TCMD
The primary concerns for TCMD are P/E Ratio, Market Cap, Profit Margin.
Key Dynamics to Monitor
MRK profiles as a value stock while TCMD is a growth play — different risk/reward profiles.
TCMD carries more volatility with a beta of 0.83 — expect wider price swings.
TCMD is growing revenue faster at 22.8% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
TCMD scores higher overall (52/100 vs 50/100) and 22.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Tactile Systems Technology Inc
HEALTHCARE · MEDICAL DEVICES · USA
Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United States. The company is headquartered in Minneapolis, Minnesota.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?